The Agency is informed by the regional health agencies of any failure to comply with the rules applicable to the medical and biological activities falling within its remit. It shall propose to the Minister for Health any measures required to remedy the situation.
It informs the Agence nationale de sécurité du médicament et des produits de santé of any breaches of the rules of good practice referred to in articles L. 1235-5 and L. 1245-6. It shall also inform the Agency of any other practice likely to adversely affect the quality or safety of the products referred to in article L. 5311-1.